Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Monica M Gaffney; Paul P Belliveau; Linda M Spooner

doi:10.1345/aph.1m160

Apricitabine: A Nucleoside Reverse Transcriptase Inhibitor for HIV Infection

Annals of Pharmacotherapy ◽

10.1345/aph.1m160 ◽

2009 ◽

Vol 43 (10) ◽

pp. 1676-1683 ◽

Cited By ~ 2

Author(s):

Monica M Gaffney ◽

Paul P Belliveau ◽

Linda M Spooner

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd009390 ◽

2011 ◽

Author(s):

Mario Cruciani ◽

Arturo J Martí-Carvajal ◽

Carlo Mengoli ◽

Giovanni Serpelloni ◽

Chiara Bovo ◽

...

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor ◽

Nrti Backbone

Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd008740 ◽

2010 ◽

Cited By ~ 6

Author(s):

Alicen Spaulding ◽

George W Rutherford ◽

Nandi Siegfried

Keyword(s):

Combination Therapy ◽

Hiv Infection ◽

Reverse Transcriptase ◽

Drug Combination ◽

Initial Treatment ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Drug Combination Therapy ◽

Reverse Transcriptase Inhibitor

Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection

Antiviral Chemistry and Chemotherapy ◽

10.1177/095632020701800201 ◽

2007 ◽

Vol 18 (2) ◽

pp. 61-70 ◽

Cited By ~ 13

Author(s):

Mark A Wainberg ◽

Pedro Cahn ◽

Richard C Bethell ◽

James Sawyer ◽

Susan Cox

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infection

Drugs of Today ◽

10.1358/dot.2020.56.2.3109966 ◽

2020 ◽

Vol 56 (2) ◽

pp. 113 ◽

Cited By ~ 2

Author(s):

R. Talwani ◽

Z. Temesgen

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Efavirenz versus nevirapine as a non-nucleoside reverse transcriptase inhibitor in initial combination antiretroviral therapy for HIV infection

10.1002/14651858.cd004246.pub2 ◽

2009 ◽

Cited By ~ 2

Author(s):

Lawrence CE Mbuagbaw ◽

James H Irlam

Keyword(s):

Antiretroviral Therapy ◽

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Combination Antiretroviral Therapy ◽

Reverse Transcriptase Inhibitor ◽

Initial Combination

Novel nucleoside reverse transcriptase inhibitor (4’-Ethynyl-2-Fluoro-2’-Deoxyadenosine) completely blocks HIV Infection of Langerhans Cells

Journal of Dermatological Science ◽

10.1016/j.jdermsci.2012.11.391 ◽

2013 ◽

Vol 69 (2) ◽

pp. e30

Author(s):

Takamitsu Matsuzawa ◽

Tatsuyoshi Kawamura ◽

Youichi Ogawa ◽

Andrew Blauvelt ◽

Hiroaki Mitsuya ◽

...

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Langerhans Cells ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection

AIDS ◽

10.1097/qad.0b013e32834d0c20 ◽

2011 ◽

Vol 25 (18) ◽

pp. 2269-2278 ◽

Cited By ~ 19

Author(s):

Richard H. Haubrich ◽

Sharon A. Riddler ◽

Heather Ribaudo ◽

Gregory DiRenzo ◽

Karin L. Klingman ◽

...

Keyword(s):

Hiv Infection ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

First Line ◽

First Line Therapy ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

Line Therapy ◽

Reverse Transcriptase Inhibitor

Apricitabine – a novel nucleoside reverse transcriptase inhibitor for the treatment of HIV infection that is refractory to existing drugs

Expert Opinion on Investigational Drugs ◽

10.1517/13543780802641337 ◽

2008 ◽

Vol 18 (2) ◽

pp. 199-209 ◽

Cited By ~ 11

Author(s):

Susan Cox ◽

Justine Southby

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor

Abacavir versus other nucleoside reverse transcriptase inhibitor (NRTI) backbone therapies for treatment of HIV infection

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd009390.pub2 ◽

2018 ◽

Author(s):

Mario Cruciani ◽

Arturo J Martí-Carvajal ◽

Carlo Mengoli ◽

Giovanni Serpelloni ◽

Chiara Bovo ◽

...

Keyword(s):

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor ◽

Nrti Backbone

Decrease of vitamin D concentration in patients with HIV infection on a Non Nucleoside Reverse Transcriptase Inhibitor containing regimen

AIDS Research and Therapy ◽

10.1186/1742-6405-7-40 ◽

2010 ◽

Vol 7 (1) ◽

pp. 40 ◽

Cited By ~ 42

Author(s):

Anali Conesa-Botella ◽

Eric Florence ◽

Lutgarde Lynen ◽

Robert Colebunders ◽

Joris Menten ◽

...

Keyword(s):

Vitamin D ◽

Hiv Infection ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Reverse Transcriptase Inhibitor